InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Cassella James V, Directeur du Développement. Insider active across 1 company, notably Concert Pharmaceuticals, INC.. Aggregated, 8 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €168k. History available since 16 August 2021. The latest transaction was disclosed on 15 February 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Cassella James V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
80,595 sharesCommon StockSEC:0001209191-23-016163:0
3,762 shares@ US$8.3414.7% of flowCommon StockSEC:0001209191-23-009949:0
10,106 shares@ US$8.3539.1% of flowCommon StockSEC:0001209191-23-005620:0
2,893 shares@ US$7.2510.0% of flowCommon StockSEC:0001209191-23-002551:0
3,762 shares@ US$3.096.1% of flowCommon StockSEC:0001209191-22-010072:0
75,800 sharesCommon StockSEC:0001209191-22-005876:0
2,894 shares@ US$3.194.9% of flowCommon StockSEC:0001209191-22-002401:0
8,086 shares@ US$3.2813.4% of flowCommon StockSEC:0001209191-21-051819:0
8 of 8 declarations
About Cassella James V
Cassella James V is Chief Development Officer at Concert Pharmaceuticals, INC. He has filed 8 filings in total, and across the 8 sampled recent filings between 2021-08-17 and 2023-03-06, they are all sales, for a total amount of EUR 167704.
